Lv41
748 积分 2023-08-01 加入
Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts
7小时前
待确认
HER2-targeted therapies — a role beyond breast cancer
1个月前
已完结
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
1个月前
已完结
Untangling the ErbB signalling network
1个月前
已完结
Fulzerasib plus cetuximab in first-line KRAS-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
5个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
5个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
5个月前
已完结
An Immunosuppressive Antibody–Drug Conjugate
6个月前
已完结
Opportunities and challenges of targeting cGAS–STING in cancer
6个月前
已完结
Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer
6个月前
已完结
皖公网安备34019202002308
